ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO0595

Proximal Tubule-Specific DPP4 Deletion Slows Kidney Disease Progression in Obese Mice

Session Information

  • CKD Mechanisms - 1
    October 22, 2020 | Location: On-Demand
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2103 CKD (Non-Dialysis): Mechanisms

Authors

  • Nistala, Ravi, University of Missouri, Columbia, Missouri, United States
  • Ren, Jing, University of Missouri, Columbia, Missouri, United States
  • An, Jianzhong, Suzhou Municipal Hospital, Suzhou, Jiangsu, China
  • Strawn, Tammy L., University of Missouri, Columbia, Missouri, United States
  • Rawat, Suryanshi, University of Missouri, Columbia, Missouri, United States
  • Patel, Priyanka, University of Missouri, Columbia, Missouri, United States
  • Whaley-Connell, Adam, University of Missouri, Columbia, Missouri, United States
Background

Obesity is a major risk factor for Chronic Kidney Disease progression to End Stage Renal Disease and/or Dialysis. Increased absorption of fats and/or sugars from Western Diet (WD) likely leads to kidney tubular injury in obesity. We observed that whole body dipeptidyl peptidase 4 (DPP4) deletion as well as inhibition in WD-fed mice results in decreased kidney injury which, in turn was associated with a decrease in proximal tubule DPP4. Therefore, we hypothesized that proximal tubule (PT) DPP4 activation leads to injury and progression of kidney disease.

Methods

PT-KO and WT littermates were fed a WD starting 4-6 wks of age and continued for 2 years. GFR and albuminuria were monitored periodically. Tissue histology was performed at select intervals. GeLC-MS was used to separate kidney peptides and Scaffold 4/iPathwayguide used to analyze the Proteomics data.

Results

WD-fed WT mice gained 150-200% weight of chow-fed [CD] mice and had a greater decline in GFR than CD-fed animals over 2 years (50% vs. 20%, p<0.05). WD-fed PT-KO mice had a lesser decline (~35%) when compared to WT mice. This was true for both male and female mice. Concomitantly, there was an increase in albuminuria in WD-fed WT mice that was mitigated in PT-KO mice. PAS/PSR stained sections showed worsening fibrosis, tubular dilatation and glomerulomegaly, tubular vacuolization in WD-fed WT mice that was mitigated in PT-KO mice. Oil Red O staining showed increased fat accumulation in glomeruli and tubules of WD-fed WT mice that was mitigated in KO mice. Proteomics analysis followed by immunoblots showed that WD-feeding led to an increase in cell adhesion proteins and ribosomal machinery that was significantly suppressed by KO. In addition, there was a shift towards reduction in gluconeogenesis and improved fatty acid oxidation in KO mice.

Conclusion

Obesity without diabetes can lead to rapid decline in GFR in both male and female mice. DPP4 inhibition may slow decline if started early in the course of developing obesity and/or insulin resistance.

Funding

  • NIDDK Support –